NCT04744805

Brief Summary

To review the relationship of increased face mask usage arising from lockdown measures instituted during the COVID-19 pandemic with dry eye symptoms on Chinese people, and make recommendations for mitigating potential detrimental effects on dry eye symptoms.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
6,262

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 29, 2021

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

February 4, 2021

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 5, 2021

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 6, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 9, 2021

Completed
Last Updated

February 9, 2021

Status Verified

February 1, 2021

Enrollment Period

7 days

First QC Date

February 4, 2021

Last Update Submit

February 4, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • time of face mask wear

    3 months

Study Arms (2)

mask wear

Other: face mask or not

dry eye

Other: face mask or not

Interventions

long term face mask wear

dry eyemask wear

Eligibility Criteria

Age6 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

An online survey of persons focused on face mask usage

You may qualify if:

  • age \>=8 years mental health

You may not qualify if:

  • eye diseases mental or systemic diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Fan Q, Liang M, Kong W, Zhang W, Wang H, Chu J, Fang X, Song Y, Gao W, Wang Y. Wearing face masks and possibility for dry eye during the COVID-19 pandemic. Sci Rep. 2022 Apr 13;12(1):6214. doi: 10.1038/s41598-022-07724-0.

MeSH Terms

Conditions

Dry Eye Syndromes

Interventions

MasksNuclear Receptor Subfamily 4, Group A, Member 2

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Surgical AttireEquipment and Supplies, HospitalEquipment and SuppliesProtective DevicesPersonal Protective EquipmentSurgical EquipmentManufactured MaterialsTechnology, Industry, and AgricultureOrphan Nuclear ReceptorsDNA-Binding ProteinsProteinsAmino Acids, Peptides, and ProteinsReceptors, Cytoplasmic and Nuclear

Study Officials

  • Yan Wang, director

    Tianjin Eye Hospital

    STUDY DIRECTOR

Central Study Contacts

Yan Wang, director

CONTACT

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 4, 2021

First Posted

February 9, 2021

Study Start

January 29, 2021

Primary Completion

February 5, 2021

Study Completion

February 6, 2021

Last Updated

February 9, 2021

Record last verified: 2021-02